leetnewb
Joined 4 years ago
Joined 4 years ago
Again, if your choice is improving quality of care for 100 conditions or trying to moonshot your way to curing one disease, more patients benefit from the former even if pharma also profits more.
Improving standard of care for 100 is less risky/more profitable because you have more shots at an expensive process with a high failure rate. And it is a lower bar to improve patient care than to permanently fix a medical mystery. But there is another factor. Focusing on treatment/management over cure most likely maximizes the positive impact on patients within the the constraints you work under.
There have been at least three new major treatments for a chronic thing I have that received FDA approval over my lifetime. Those treatments have had a massive impact on my quality of life, ability to have a career, etc. I don't believe that happens for me if we allocate to cures.
Matrix has a for-profit, venture funded company (Element) that is effectively behind the reference/flagship server and client implementations.
xmpp is far less centralized. Virtually all of the modern clients are single developer projects that live off day jobs and grants.
There are different ways to look at it. Matrix has done a great job at organizing resources to push the platform forward. xmpp has an impressive ecosystem and some incredible client implementations on a shoe string budget, that would probably look/function better and have lots more features given funding parity.
I think as we've seen with other projects like Immich, organizing and recruiting resources is an important part of delivering the modern experiences that users expect today from open source projects. Open source and self-hostable can't be an excuse for missing features.